MARAVAI LIFESCIENCES HOLDINGS, INC.
September 7, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-1090
| Attention: | Michael Davis |
| Joe McCann |
| Re: | Maravai LifeSciences Holdings, Inc. |
| Registration Statement on Form S-1 (File No. 333-259366) |
| Originally Filed September 7, 2021 |
| Request for Acceleration of Effective Date |
| CIK: 0001823239 |
Ladies and Gentlemen:
Maravai LifeSciences Holdings, Inc., a Delaware corporation (the Company), hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-259366), originally filed on September 7, 2021 (the Registration Statement), to 4:00 p.m., Eastern time, on September 9, 2021 or as soon thereafter as practicable.
* * * *
Please contact Robert Goedert, P.C. of Kirkland & Ellis LLP, special counsel to the Company, at (312) 862-7317, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
| Sincerely,
| ||
| MARAVAI LIFESCIENCES HOLDINGS, INC.
| ||
| By: | /s/ Carl Hull | |
| Name: | Carl Hull | |
| Title: | Chief Executive Officer | |